FdaApplication
ANDA 204989
Identifiers
- fda_app_no: ANDA204989
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2016-02-18 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RELGAABI | GABAPENTIN | 300MG | CAPSULE;ORAL |
| RELGAABI | GABAPENTIN | 200MG | CAPSULE;ORAL |
| RELGAABI | GABAPENTIN | 100MG | CAPSULE;ORAL |
| RELGAABI | GABAPENTIN | 400MG | CAPSULE;ORAL |
4 products